This article is more than 5 years old. Information may no longer be current.

VIDEO: Genotyping may influence antiplatelet therapy prescriptions

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this Cardiology Today video exclusive, Sony Tuteja, PharmD, MS, research assistant professor of translational medicine and human genetics at Penn Medicine, and Jay S. Giri, MD, MPH, director of peripheral intervention and assistant professor of medicine at the Hospital of the University of Pennsylvania and a Cardiology Today Next Gen Innovator, discuss the results of the ADAPT trial.

The results of the study, presented at the American College of Cardiology Scientific Session, showed that performing a genetic test for nonresponse to clopidogrel frequently but not exclusively influences physician choice of antiplatelet prescription after PCI.

Watch the video for more.